These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3701061)

  • 1. The kinetics of clearance of human antibody/dsDNA immune complexes from rabbit circulation. Effects of dsDNA size, rheumatoid factor, and reduction and alkylation of the antibodies.
    Taylor RP; Kujala G; Edberg JC; Foreman P; Davis JS; Wright E
    J Immunol; 1986 May; 136(10):3785-92. PubMed ID: 3701061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets.
    Taylor RP; Kujala G; Wilson K; Wright E; Harbin A
    J Immunol; 1985 Apr; 134(4):2550-8. PubMed ID: 3919101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
    Horgan C; Burge J; Crawford L; Taylor RP
    J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance kinetics and immunochemistry in rabbits of soluble antibody/DNA immune complexes. Effects of antibody class and DNA conformation.
    Edberg JC; Kujala GA; Taylor RP
    J Immunol; 1987 Jul; 139(1):180-7. PubMed ID: 3584985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
    Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid immune adherence reactivity of nascent, soluble antibody/DNA immune complexes in the circulation.
    Edberg JC; Kujala GA; Taylor RP
    J Immunol; 1987 Aug; 139(4):1240-4. PubMed ID: 3611789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analyses of C3b capture and immune adherence of IgM antibody/dsDNA immune complexes.
    Taylor RP; Wright EL; Pocanic F
    J Immunol; 1989 Dec; 143(11):3626-31. PubMed ID: 2584711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.
    Taylor RP; Burge J; Horgan C; Shasby DM
    J Immunol; 1983 Jun; 130(6):2656-62. PubMed ID: 6854016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo generation and clearance of soluble immune complexes containing IgM antibodies in normal and decomplemented rabbits.
    Brown DL; Harkiss GD
    Clin Exp Immunol; 1981 Feb; 43(2):231-9. PubMed ID: 6974064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance and organ localization of small DNA anti-DNA immune complexes in mice.
    Emlen W; Burdick G
    J Immunol; 1988 Mar; 140(6):1816-22. PubMed ID: 3257987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys.
    Reist CJ; Liang HY; Denny D; Martin EN; Scheld WM; Taylor RP
    Eur J Immunol; 1994 Sep; 24(9):2018-25. PubMed ID: 8088321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
    Doekes G; Schouten J; Cats A; Daha MR
    Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of soluble immune complexes into complement-fixing aggregates by IgM-rheumatoid factor.
    Tesar JT; Schmid FR
    J Immunol; 1970 Nov; 105(5):1206-14. PubMed ID: 5312663
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cryoglobulinemia type II].
    Madi N; Schifferli JA
    Nephrologie; 1990; 11(4):237-41. PubMed ID: 2074925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on rheumatoid factor: I. The effect of rheumatoid factor on the clearance of preformed immune complexes in mice.
    Hogben DN; Devey ME
    Clin Exp Immunol; 1986 Dec; 66(3):648-53. PubMed ID: 3568452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of DNA/anti-DNA complexes. II. Salt lability and avidity.
    Riley RL; Addis DJ; Taylor RP
    J Immunol; 1980 Jan; 124(1):1-7. PubMed ID: 6985634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
    Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN
    Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system.
    Skogh T; Stendahl O
    Immunology; 1983 May; 49(1):53-9. PubMed ID: 6404812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.